BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10928162)

  • 1. Erythrocyte polyamines and prognosis in colorectal cancer patients.
    Linsalata M; Leo S; Guerra V; Di Leo A
    Anticancer Res; 2000; 20(3B):2113-7. PubMed ID: 10928162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of tissue polyamine levels in human colorectal carcinoma.
    Linsalata M; Caruso MG; Leo S; Guerra V; D'Attoma B; Di Leo A
    Anticancer Res; 2002; 22(4):2465-9. PubMed ID: 12174945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade.
    Weiss TS; Bernhardt G; Buschauer A; Thasler WE; Dolgner D; Zirngibl H; Jauch KW
    Int J Colorectal Dis; 2002 Nov; 17(6):381-7. PubMed ID: 12355213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of erythrocyte polyamines as a predictive method in tumour diagnosis. An animal study with chemically induced tumours.
    Quemener V; Havouis R; Khan NA; Martin C; Bouet F; Moulinoux JP
    Anticancer Res; 1995; 15(6B):2517-22. PubMed ID: 8669816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyamines levels in colorectal cancer: new markers?
    Naso P; Lanteri R; Acquaviva R; Licata F; Bonanno G; Licata A
    Hepatogastroenterology; 2005; 52(62):433-6. PubMed ID: 15816451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyamine levels and ornithine decarboxylase activity in blood and erythrocytes in human diseases.
    Stabellini G; Calastrini C; Gagliano N; Dellavia C; Moscheni C; Vizzotto L; Occhionorelli S; Gioia M
    Int J Clin Pharmacol Res; 2003; 23(1):17-22. PubMed ID: 14621069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The diagnostic value of erythrocyte polyamines (EPA) in prostatic adenocarcinoma (PA): apropos of 100 patients].
    Cipolla B; Guille F; Quemener V; Lévêque JM; Moulinoux JP; Lobel B
    Prog Urol; 1992 Feb; 2(1):50-7. PubMed ID: 1284385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of erythrocyte polyamine levels and growth rate of transplantable tumors in rats.
    Grossie VB; Nishioka K; Ota DM; Martin RG
    Cancer Res; 1986 Jul; 46(7):3464-8. PubMed ID: 3708578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte-binding polyamine as a tumor growth marker for human hepatocellular carcinoma.
    Nishiguchi S; Tamori A; Koh N; Fujimoto S; Takeda T; Shiomi S; Oka H; Yano Y; Otani S; Kuroki T
    Hepatogastroenterology; 2002; 49(44):504-7. PubMed ID: 11995483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polyamine evaluation in serum and erythrocytes of pediatric patients with neoplasms].
    Sicca E; Gallesio C; Colombatto S; Madon E
    Minerva Pediatr; 1997; 49(1-2):21-7. PubMed ID: 9132557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in blood polyamine levels in human acute pancreatitis.
    Jin HT; Räty S; Minkkinen M; Järvinen S; Sand J; Alhonen L; Nordback I
    Scand J Gastroenterol; 2009; 44(8):1004-11. PubMed ID: 19444716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in plasma, erythrocytes and tissue polyamine levels in patients with colorectal cancer].
    Miyata J
    Nihon Geka Gakkai Zasshi; 1988 Apr; 89(4):547-59. PubMed ID: 3405195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical significance of determination of red blood cell and urinary polyamines in gynecologic malignancy (author's transl)].
    Hayase R; Yonezawa M; Hiramatsu Y; Eguchi K; Sekiba K
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):107-16. PubMed ID: 7229447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamines and estrogen-receptor concentrations in human colorectal carcinomas.
    Russo F; Linsalata M; Messa C; Cavallini A; Notarnicola M; Guerra V; Lantone G; Lacatena M; Di Leo A
    Ital J Gastroenterol; 1992 Jan; 24(1):8-12. PubMed ID: 1571579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
    Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
    An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human erythrocyte polyamine levels after partial hepatectomy.
    Tsukamoto T; Kinoshita H; Hirohashi K; Kubo S; Otani S
    Hepatogastroenterology; 1997; 44(15):744-50. PubMed ID: 9222683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
    Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Yokoe T; Tanaka K; Kusunoki M
    Ann Surg Oncol; 2008 Jun; 15(6):1617-24. PubMed ID: 18368454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of plasma D-dimer levels in patients with colorectal cancer.
    Kilic M; Yoldas O; Keskek M; Ertan T; Tez M; Gocmen E; Koc M
    Colorectal Dis; 2008 Mar; 10(3):238-41. PubMed ID: 17868411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.